نتایج جستجو برای: slco1b1

تعداد نتایج: 546  

Journal: :Pharmacogenetics and genomics 2006
Aleksi Tornio Juha Vakkilainen Mikko Neuvonen Janne T Backman Pertti J Neuvonen Mikko Niemi

OBJECTIVE Organic anion transporting polypeptide 1B1 (OATP1B1, encoded by SLCO1B1 gene) is a hepatic uptake transporter, and its genetic variability is associated with pharmacokinetics and muscle toxicity risk of simvastatin. We examined the possible effects of variations in the SLCO1B1 gene on the pharmacokinetics of lovastatin in a prospective genotype panel study. PARTICIPANTS AND METHODS ...

2017
JP Kitzmiller JA Luzum A Dauki RM Krauss MW Medina

Cholesterol-lowering response to 40 mg simvastatin daily for 6 weeks was examined for associations with common genetic polymorphisms in key genes affecting simvastatin metabolism (CYP3A4 and CYP3A5) and transport (SLCO1B1). In white people (n = 608), SLCO1B1 521C was associated with lesser reductions of total and low-density lipoprotein cholesterol. Associations between SLCO1B1 521C and cholest...

Journal: :Jornal de pediatria 2013
Jiebo Liu Jun Long Shaofang Zhang Xiaoyan Fang Yuyuan Luo

OBJECTIVE To determine whether three variants (388 G>A, 521 T>C, and 463 C>A) of the solute carrier organic anion transporter family member 1B1 (SLCO1B1) are associated with neonatal hyperbilirubinemia. DATA SOURCE The China National Knowledge Infrastructure and MEDLINE databases were searched. The systematic review with meta-analysis included genetic studies which assessed the association be...

2013
Jiebo Liu Jun Long Shaofang Zhang Xiaoyan Fang Yuyuan Luo

BACKGROUND To evaluate the association between the genetic polymorphism of the solute carrier organic anion transporter family member 1B1 (SLCO1B1, also known as organic anion transport polypeptide C) and hyperbilirubinemia in Chinese neonates. METHODS 183 infants with hyperbilirubinemia and 192 control subjects from the Fifth People's Hospital of Shenzhen were recruited. Polymerase chain rea...

Journal: :Clinical pharmacology and therapeutics 2014
L B Ramsey S G Johnson K E Caudle C E Haidar D Voora R A Wilke W D Maxwell H L McLeod R M Krauss D M Roden Q Feng R M Cooper-DeHoff L Gong T E Klein M Wadelius M Niemi

Simvastatin is among the most commonly used prescription medications for cholesterol reduction. A single coding single-nucleotide polymorphism, rs4149056T>C, in SLCO1B1 increases systemic exposure to simvastatin and the risk of muscle toxicity. We summarize evidence from the literature supporting this association and provide therapeutic recommendations for simvastatin based on SLCO1B1 genotype....

Journal: :Pharmacogenetics and genomics 2013
Bani Tamraz Hisayo Fukushima Alan R Wolfe Rüdiger Kaspera Rheem A Totah James S Floyd Benjamin Ma Catherine Chu Kristin D Marciante Susan R Heckbert Bruce M Psaty Deanna L Kroetz Pui-Yan Kwok

OBJECTIVE Genetic variation in drug metabolizing enzymes and membrane transporters as well as concomitant drug therapy can modulate the beneficial and the deleterious effects of drugs. We investigated whether patients exhibiting rhabdomyolysis who were taking cerivastatin possess functional genetic variants in SLCO1B1 and whether they were on concomitant medications that inhibit OATP1B1, result...

2016
Nan Shu Mengyue Hu Zhaoli Ling Peihua Liu Fan Wang Ping Xu Zeyu Zhong Binbin Sun Mian Zhang Feng Li Qiushi Xie Xiaodong Liu Li Liu

Liver injury is a common adverse effect of atorvastatin. This study aimed to investigate atorvastatin-induced hepatotoxicity in diabetic rats induced by high-fat diet combined with streptozotocin. The results showed that 40 mg/kg atorvastatin was lethal to diabetic rats, whose mean survival time was 6.2 days. Severe liver injury also occurred in diabetic rats treated with 10 mg/kg and 20 mg/kg ...

2010
Wenjun Ni Jia Ji Zunyan Dai Audrey Papp Amy J. Johnson Sunjoo Ahn Katherine L. Farley Thomas S. Lin James T. Dalton Xiaobai Li David Jarjoura John C. Byrd Wolfgang Sadee Michael R. Grever Mitch A. Phelps

BACKGROUND Flavopiridol is a cyclin-dependent kinase inhibitor in phase II clinical development for treatment of various forms of cancer. When administered with a pharmacokinetically (PK)-directed dosing schedule, flavopiridol exhibited striking activity in patients with refractory chronic lymphocytic leukemia. This study aimed to evaluate pharmacogenetic factors associated with inter-individua...

Journal: :Journal of gastroenterology and hepatology 2014
Akiko Shiotani Takahisa Murao Yoshihiko Fujita Yoshinori Fujimura Takashi Sakakibara Kazuto Nishio Ken Haruma

BACKGROUND AND AIM In our previous study, the SLCO1B1 521TT genotype and the SLCO1B1*1b haplotype were significantly associated with the risk of peptic ulcer in patients taking low-dose aspirin (LDA). The aim of the present study was to investigate pharmacogenomic profile of LDA-induced peptic ulcer and ulcer bleeding. METHODS Patients taking 100 mg of enteric-coated aspirin for cardiovascula...

2011
Alice C. Rodrigues Paula M. S. Perin Sheila G. Purim Vivian N. Silbiger Fabiana D. V. Genvigir Maria Alice V. Willrich Simone S. Arazi Andre D. Luchessi Mario H. Hirata Marcia M. S. Bernik Egidio L. Dorea Carla Santos Andre A. Faludi Marcelo C. Bertolami Antonio Salas Ana Freire Maria V. Lareu Christopher Phillips Liliana Porras-Hurtado Manuel Fondevila Angel Carracedo Rosario D. C. Hirata

AIMS The relationship between variants in SLCO1B1 and SLCO2B1 genes and lipid-lowering response to atorvastatin was investigated. MATERIAL AND METHODS One-hundred-thirty-six unrelated individuals with hypercholesterolemia were selected and treated with atorvastatin (10 mg/day/4 weeks). They were genotyped with a panel of ancestry informative markers for individual African component of ancestr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید